Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SILVESTRINI R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 92 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Daidone, MG; Costa, A; Silvestrini, R
      Cell proliferation markers in human solid tumors: Assessing their impact in clinical oncology

      METHODS IN CELL BIOLOGY, VOL 64
    2. Silvestrini, R
      Relevance of DNA-ploidy as a prognostic instrument for solid tumors

      ANNALS OF ONCOLOGY
    3. Silvestrini, R; Luisi, A; Zambetti, M; Cipriani, S; Valagussa, P; Bonadonna, G; Daidone, MG
      Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer

      INTERNATIONAL JOURNAL OF CANCER
    4. Daidone, MG; Luisi, A; Martelli, G; Benini, E; Veneroni, S; Tomasic, G; De Palo, G; Silvestrini, R
      Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women

      BRITISH JOURNAL OF CANCER
    5. Daidone, MG; Luisi, A; Veneroni, S; Benini, E; Silvestrini, R
      Clinical studies of Bcl-2 and treatment benefit in breast cancer patients

      ENDOCRINE-RELATED CANCER
    6. Favaloro, EJ; Silvestrini, R; Mohammed, A
      Clinical utility of anticardiolipin antibody assays: High inter-laboratoryvariation and limited consensus by participants of external quality assurance programs signals a cautious approach

      PATHOLOGY
    7. Jolles, S; Deacock, S; Turnbull, W; Silvestrini, R; Bunn, C; White, P; Ward, M
      Atypical C-ANCA following high dose intravenous immunoglobulin

      JOURNAL OF CLINICAL PATHOLOGY
    8. Daidone, MG; Veneroni, S; Benini, E; Tomasic, G; Coradini, D; Mastore, M; Brambilla, C; Ferrari, L; Silvestrini, R
      Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer

      INTERNATIONAL JOURNAL OF CANCER
    9. Savige, J; Gillis, D; Benson, E; Davies, D; Esnault, V; Falk, RJ; Hagen, EC; Jayne, D; Jennette, JC; Paspaliaris, B; Pollock, W; Pusey, C; Savage, COS; Silvestrini, R; van der Woude, F; Wieslander, J; Wiik, A
      International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA)

      AJCP. American journal of clinical pathology
    10. DAIDONE MG; BENINI E; RAO S; PILOTTI S; SILVESTRINI R
      FIXATION TIME AND MICROWAVE-OVEN IRRADIATION AFFECT IMMUNOCYTOCHEMICAL P53 DETECTION IN FORMALIN-FIXED PARAFFIN SECTIONS

      Applied immunohistochemistry
    11. BOMBARDIERI E; SEREGNI E; DAIDONE MG; BENINI E; MASSARON S; FERRARI L; DIFRONZO G; SILVESTRINI R
      P53 ACCUMULATION IN PRIMARY BREAST-CANCER - A COMPARISON BETWEEN IMMUNOHISTOCHEMISTRY AND A NOVEL LUMINOMETRIC IMMUNOASSAY

      Tumor biology
    12. BEARZATTO A; ORLANDI L; SILVESTRINI R; BELLI F; CASCINELLI N; ZAFFARONI N
      COMBINED EFFECTS OF INTERFERON-ALPHA-2A AND 13-CIS-RETINOIC ACID ON HUMAN-MELANOMA CELL-GROWTH AND STAT PROTEIN EXPRESSION

      Melanoma research
    13. SILVESTRINI R; COSTA A; LEQUAGLIE C; MOCHEN C; VENERONI S; LEUTNER M; RAVASI G
      BCL-2 PROTEIN AND PROGNOSIS IN PATIENTS WITH POTENTIALLY CURABLE NONSMALL-CELL LUNG-CANCER

      Virchows Archiv
    14. ZAFFARONI N; VILLA R; FOLINI M; DAIDONE MG; SILVESTRINI R
      POTENTIAL OF PEPTIDE NUCLEIC-ACIDS AS INHIBITORS OF HUMAN TELOMERASE CATALYTIC ACTIVITY

      Annals of oncology
    15. SILVESTRINI R; LUISI A; DAIDONE MG; DIMAURO MG
      EFFECT OF MENSTRUAL PHASE ON CELL PROLIFERATIVE RATE OF BREAST-CANCER

      Breast cancer research and treatment
    16. Amadori, D; Silvestrini, R
      Prognostic and predictive value of thymidine labelling index in breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    17. BENINI E; COSTA A; ABOLAFIO G; SILVESTRINI R
      P53 EXPRESSION IN HUMAN CARCINOMAS - COULD FLOW-CYTOMETRY BE AN ALTERNATIVE TO IMMUNOHISTOCHEMISTRY

      The Journal of histochemistry and cytochemistry
    18. SAVIGE JA; PASPALIARIS B; SILVESTRINI R; DAVIES D; NIKOLOUTSOPOULOS T; STURGESS A; NEIL J; POLLOCK W; DUNSTER K; HENDLE M
      A REVIEW OF IMMUNOFLUORESCENT PATTERNS ASSOCIATED WITH ANTINEUTROPHILCYTOPLASMIC ANTIBODIES (ANCA) AND THEIR DIFFERENTIATION FROM OTHER ANTIBODIES

      Journal of Clinical Pathology
    19. Yu, LJ; Orlandi, L; Wang, P; Orr, MS; Senderowicz, AM; Sausville, EA; Silvestrini, R; Watanabe, N; Piwnica-Worms, H; O'Connor, PM
      UCN-01 abrogates G(2) arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the Cdc25C phosphatase

      JOURNAL OF BIOLOGICAL CHEMISTRY
    20. COSTA A; LICITRA L; VENERONI S; DAIDONE MG; GRANDI C; CAVINA R; MOLINARI R; SILVESTRINI R
      BIOLOGICAL MARKERS AS INDICATORS OF PATHOLOGICAL RESPONSE TO PRIMARY CHEMOTHERAPY IN ORAL-CAVITY CANCERS

      International journal of cancer
    21. ORLANDI L; ZAFFARONI N; BEARZATTO A; VILLA R; DEMARCO C; SILVESTRINI R
      LONIDAMINE AS A MODULATOR OF TAXOL ACTIVITY IN HUMAN OVARIAN-CANCER CELLS - EFFECTS ON CELL-CYCLE AND INDUCTION OF APOPTOSIS

      International journal of cancer
    22. SILVESTRINI R; DAIDONE MG; VENERONI S; BENINI E; SCARFONE G; ZANABONI F; VILLA A; PRESTI M; DANESE S; BOLIS G
      THE CLINICAL PREDICTIVITY OF BIOMARKERS OF STAGE III-IV EPITHELIAL OVARIAN-CANCER IN A PROSPECTIVE RANDOMIZED TREATMENT PROTOCOL

      Cancer
    23. ZAFFARONI N; SILVESTRINI R; ORLANDI L; BEARZATTO A; GORNATI D; VILLA R
      INDUCTION OF APOPTOSIS BY TAXOL AND CISPLATIN AND EFFECT ON CELL CYCLE-RELATED PROTEINS IN CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT HUMAN OVARIAN-CANCER CELLS

      British Journal of Cancer
    24. VILLA R; ZAFFARONI N; FOLINI M; MARTELLI G; DEPALO G; DAIDONE MG; SILVESTRINI R
      TELOMERASE ACTIVITY IN BENIGN AND MALIGNANT BREAST-LESIONS - A PILOT PROSPECTIVE-STUDY ON FINE-NEEDLE ASPIRATES

      Journal of the National Cancer Institute
    25. VENERONI S; SILVESTRINI R; COSTA A; SALVATORI P; FARANDA A; MOLINARI R
      BIOLOGICAL INDICATORS OF SURVIVAL IN PATIENTS TREATED BY SURGERY FOR SQUAMOUS-CELL CARCINOMA OF THE ORAL CAVITY AND OROPHARYNX

      Oral Oncology
    26. COSTA A; VILLA R; ZAFFARONI N; SANTI S; BEARZATTO A; SILVESTRINI R
      TAXOL INDUCES APOPTOSIS IN VARIOUS CANCER CELL-LINES - COMPARISON AMONG DIFFERENT METHODOLOGICAL APPROACHES

      European journal of histochemistry
    27. SAVIGE J; PASPALIARIS B; SILVESTRINI R; NEIL J; DUNSTER K; DAVIES D
      IMMUNOFLUORESCENT PATTERNS ASSOCIATED WITH ANTINEUTROPHIL CYTOPLASMICANTIBODIES (ANCA) AND THEIR DIFFERENTIATION FROM OTHER AUTOANTIBODIESAND ALLOANTIBODIES

      Journal of the American Society of Nephrology
    28. ZAFFARONI N; VILLA R; GORNATI D; FOLINI M; SILVESTRINI R
      SCHEDULE-DEPENDENT MODULATION OF IDARUBICIN CYTOTOXICITY BY LONIDAMINE IN HUMAN LYMPHOMA CELL-LINES

      International journal of oncology
    29. DAIDONE MG; RICARDI U; VENERONI S; FARANDA A; BENINI E; URGESI A; SANNAZZARI GL; SILVESTRINI R
      BIOLOGICAL PREDICTORS OF RESPONSE TO RADIOTHERAPY IN CERVICAL CARCINOMAS

      International journal of oncology
    30. BENINI E; RAO S; DAIDONE MG; PILOTTI S; SILVESTRINI R
      IMMUNOREACTIVITY TO MIB-1 IN BREAST-CANCER - METHODOLOGICAL ASSESSMENT AND COMPARISON WITH OTHER PROLIFERATION, INDEXES

      Cell proliferation
    31. MOCHEN C; GIARDINI R; COSTA A; SILVESTRINI R
      MIB-1 AND S-PHASE CELL FRACTION PREDICT SURVIVAL IN NON-HODGKINS-LYMPHOMAS

      Cell proliferation
    32. GORNATI D; ZAFFARONI N; VILLA R; DEMARCO C; SILVESTRINI R
      MODULATION OF MELPHALAN AND CISPLATIN CYTOTOXICITY IN HUMAN OVARIAN-CANCER CELLS RESISTANT TO ALKYLATING DRUGS

      Anti-cancer drugs
    33. FARANDA A; COSTA A; CANOVA S; ABOLAFIO G; SILVESTRINI R
      IMAGE AND FLOW CYTOMETRIC ANALYSES OF DNA CONTENT IN HUMAN SOLID TUMORS - A COMPARATIVE-STUDY

      Analytical and quantitative cytology and histology
    34. COSTA A; DOCI R; MOCHEN C; BIGNAMI P; FARANDA A; GENNARI L; SILVESTRINI R
      CELL PROLIFERATION-RELATED MARKERS IN COLORECTAL LIVER METASTASES - CORRELATION WITH PATIENT PROGNOSIS

      Journal of clinical oncology
    35. SILVESTRINI R
      P53 ALTERATIONS IN HUMAN CANCERS - BASIC INFORMATION AND CLINICAL-APPLICATIONS

      European journal of cell biology
    36. ORLANDI L; ZAFFARONI N; BEARZATTO A; SILVESTRINI R
      EFFECTS OF TAXOL ON PROTEINS THAT REGULATE CELL-CYCLE PROGRESSION ANDAPOPTOSIS

      European journal of cell biology
    37. VILLA R; ZAFFARONI N; DAIDONE MG; SILVESTRINI R
      TELOMERES AND TELOMERASE - ROLE IN HUMAN TUMOR EVOLUTION AND RELEVANCE AS TARGETS FOR NEW THERAPIES

      European journal of cell biology
    38. MARIANI L; CORADINI D; BIGANZOLI E; BORACCHI P; MARUBINI E; PILOTTI S; SALVADORI B; SILVESTRINI R; VERONESI U; ZUCALI R; RILKE F
      PROGNOSTIC FACTORS FOR METACHRONOUS CONTRALATERAL BREAST-CANCER - A COMPARISON OF THE LINEAR COX REGRESSION-MODEL AND ITS ARTIFICIAL NEURAL-NETWORK EXTENSION

      Breast cancer research and treatment
    39. AMADORI D; VOLPI A; MALTONI R; NANNI O; AMADUCCI L; AMADORI A; GIUNCHI DC; VIO A; SARAGONI A; SILVESTRINI R
      CELL-PROLIFERATION AS A PREDICTOR OF RESPONSE TO CHEMOTHERAPY IN METASTATIC BREAST-CANCER - A PROSPECTIVE-STUDY

      Breast cancer research and treatment
    40. SILVESTRINI R; GORNATI D; ZAFFARONI N; BEARZATTO A; DEMARCO C
      MODULATION BY LONIDAMINE ON THE COMBINED ACTIVITY OF CISPLATIN AND EPIDOXORUBICIN IN HUMAN BREAST-CANCER CELLS

      Breast cancer research and treatment
    41. SILVESTRINI R; DAIDONE MG; LUISI A; MASTORE M; LEUTNER M; SALVADORI B
      CELL-PROLIFERATION IN 3.800 NODE-NEGATIVE BREAST CANCERS - CONSISTENCY OVER TIME OF BIOLOGICAL AND CLINICAL INFORMATION PROVIDED BY H-3 THYMIDINE LABELING INDEX

      International journal of cancer
    42. DAIDONE MG; SILVESTRINI R; BENINI E; GRIGIONI WF; DERRICO A
      EXPRESSION OF HIGH-AFFINITY 67-KDA LAMININ RECEPTORS IN PRIMARY BREAST CANCERS AND METACHRONOUS METASTATIC LESIONS OR CONTRALATERAL CANCERS

      British Journal of Cancer
    43. SILVESTRINI R; VENERONI S; BENINI E; DAIDONE MG; LUISI A; LEUTNER M; MAUCIONE A; KENDA R; ZUCALI R; VERONESI U
      EXPRESSION OF P53, GLUTATHIONE-S-TRANSFERASE-PI, AND BCL-2 PROTEINS AND BENEFIT FROM ADJUVANT RADIOTHERAPY IN BREAST-CANCER

      Journal of the National Cancer Institute
    44. SILVESTRINI R; DAIDONE MG; BENINI E; FARANDA A; TOMASIC G; BORACCHI P; SALVADORI B; VERONESI U
      VALIDATION OF P53 ACCUMULATION AS A PREDICTOR OF DISTANT METASTASIS AT 10 YEARS OF FOLLOW-UP IN 1400 NODE-NEGATIVE BREAST CANCERS

      Clinical cancer research
    45. DAIDONE MG; BENINI E; VALENTINIS B; BOLIS G; VILLA A; SILVESTRINI R
      P53 EXPRESSION, DNA CONTENT AND CELL-PROLIFERATION IN PRIMARY AND SYNCHRONOUS METASTATIC LESIONS FROM OVARIAN SURFACE EPITHELIAL-STROMAL TUMORS

      European journal of cancer
    46. ZAFFARONI N; ORLANDI L; GORNATI D; DEMARCO C; VAGLINI M; SILVESTRINI R
      FLUDARABINE AS A MODULATOR OF CISPLATIN ACTIVITY IN HUMAN TUMOR PRIMARY CULTURES AND ESTABLISHED CELL-LINES

      European journal of cancer
    47. SUPINO R; CASERINI C; ORLANDI L; ZAFFARONI N; SILVESTRINI R; VAGLINI M; ZUNINO F
      MODULATION OF MELPHALAN CYTOTOXIC ACTIVITY IN HUMAN-MELANOMA CELL-LINES

      Anti-cancer drugs
    48. FARANDA A; SILVESTRINI R; CANOVA S; COSTA A
      IMAGE-ANALYSIS FOR THE EVALUATION OF P53 EXPRESSION IN HUMAN CANCERS

      Analytical cellular pathology
    49. SILVESTRINI R; BENINI E; VENERONI S; DAIDONE MG; TOMASIC G; SQUICCIARINI P; SALVADORI B
      P53 AND BCL-2 EXPRESSION CORRELATES WITH CLINICAL OUTCOME IN A SERIESOF NODE-POSITIVE BREAST-CANCER PATIENTS

      Journal of clinical oncology
    50. VILLA R; ZAFFARONI N; BEARZATTO A; COSTA A; SICHIROLLO A; SILVESTRINI R
      EFFECT OF IONIZING-RADIATION ON CELL-CYCLE PROGRESSION AND CYCLIN BETA-1 EXPRESSION IN HUMAN-MELANOMA CELLS

      International journal of cancer
    51. ORLANDI L; ZAFFARONI N; BEARZATTO A; SILVESTRINI R
      EFFECT OF MELPHALAN AND HYPERTHERMIA ON P34(CDC2) KINASE-ACTIVITY IN HUMAN-MELANOMA CELLS

      British Journal of Cancer
    52. COSTA A; SILVESTRINI R; MOCHEN C; LEQUAGLIE C; BORACCHI P; FARANDA A; VESSECCHIA G; RAVASI G
      P53 EXPRESSION, DNA-PLOIDY AND S-PHASE CELL FRACTION IN OPERABLE LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER

      British Journal of Cancer
    53. R.Silvestrini; A.Costa; A.Faranda
      Biological prospectives to define prognosis and treatment strategies in liver metastases from colorectal cancer.

      Annali Italiani di Chirurgia
    54. ZAFFARONI N; BENINI E; GORNATI D; BEARZATTO A; SILVESTRINI R
      LACK OF A CORRELATION BETWEEN P53 PROTEIN EXPRESSION AND RADIATION RESPONSE IN HUMAN TUMOR PRIMARY CULTURES

      Stem cells
    55. GORNATI D; ZAFFARONI N; ORLANDI L; DIFRONZO G; SILVESTRINI R
      COMBINED EFFECTS OF LONIDAMINE AND TAMOXIFEN IN HUMAN BREAST-CANCER CELL-LINES

      International journal of oncology
    56. ORLANDI L; ZAFFARONI N; BEARZATTO A; COSTA A; SUPINO R; VAGLINI M; SILVESTRINI R
      EFFECT OF MELPHALAN AND HYPERTHERMIA ON CELL-CYCLE PROGRESSION AND CYCLIN B-1 EXPRESSION IN HUMAN-MELANOMA CELLS

      Cell proliferation
    57. SILVESTRINI R
      P53 ALTERATIONS IN HUMANS - BASIC INFORMATION AND CLINICAL-APPLICATIONS

      European journal of cancer
    58. SILVESTRINI R; DAIDONE MG; LUISI A; BORACCHI P; MEZZETTI M; DIFRONZO G; ANDREOLA S; SALVADORI B; VERONESI U
      BIOLOGIC AND CLINICOPATHOLOGICAL FACTORS AS INDICATORS OF SPECIFIC RELAPSE TYPES IN NODE-NEGATIVE BREAST-CANCER

      Journal of clinical oncology
    59. SILVESTRINI R; COSTA A
      CELL-PROLIFERATION AND RELATED GENES AS INDICATORS OF PROGNOSIS IN COLORECTAL CANCERS

      Journal of experimental & clinical cancer research
    60. BOZZETTI F; BORACCHI P; COSTA A; COZZAGLIO L; BATTISTA A; GIORI A; LAMONICA G; SILVESTRINI R
      RELATIONSHIP BETWEEN NUTRITIONAL-STATUS AND TUMOR-GROWTH IN HUMANS

      Tumori
    61. DAIDONE MG; MARTELLI G; PILOTTI S; LUISI A; FARISELLI G; DEPALO G; DEYOLDI GC; SILVESTRINI R
      CONTRIBUTION OF PLOIDY AND CELL-KINETICS FROM FINE-NEEDLE ASPIRATES FOR THE DIAGNOSIS OF BREAST-LESIONS - STUDY OF 606 CONSECUTIVE CASES

      Cytometry
    62. COSTA A; MARASCA R; VALENTINIS B; SAVARINO M; FARANDA A; SILVESTRINI R; TORELLI G
      P53 GENE POINT MUTATIONS IN RELATION TO P53 NUCLEAR-PROTEIN ACCUMULATION IN COLORECTAL CANCERS

      Journal of pathology
    63. BENINI E; SILVESTRINI R; DAIDONE MG; CANOVA S
      DETECTION OF P53 EXPRESSION AND S-PHASE CELL FRACTION IN PARAFFIN-EMBEDDED TISSUE BY A DOUBLE-LABELING TECHNIQUE

      The Journal of histochemistry and cytochemistry
    64. DAIDONE MG; SILVESTRINI R; LUISI A; MASTORE M; BENINI E; VENERONI S; BRAMBILLA C; FERRARI L; GRECO M; ANDREOLA S; VERONESI U
      CHANGES IN BIOLOGICAL MARKERS AFTER PRIMARY CHEMOTHERAPY FOR BREAST CANCERS

      International journal of cancer
    65. SILVESTRINI R; RAO S; BENINI E; DAIDONE MG; PILOTTI S
      IMMUNOHISTOCHEMICAL DETECTION OF P53 IN CLINICAL BREAST CANCERS - A LOOK AT METHODOLOGIC APPROACHES

      Journal of the National Cancer Institute
    66. SILVESTRINI R; DELENA M
      LONIDAMINE - PROCEEDINGS OF A SYMPOSIUM HELD DURING THE JOINT AIOM AND SIC MEETING IN BARI, OCTOBER 17, 1993 - INTRODUCTION

      International journal of oncology
    67. ZAFFARONI N; BEARZATTO A; GORNATI D; SILVESTRINI R
      EFFECT OF LONIDAMINE ON THE CYTOTOXIC ACTIVITY OF CISPLATIN, MITOMYCIN-C AND BCNU IN HUMAN OVARIAN AND COLON-CARCINOMA CELLS

      International journal of oncology
    68. FARANDA A; COSTA A; SILVESTRINI R; QUAGLIUOLO V; GENNARI L
      S-PHASE CELL FRACTION IN THE PROGNOSIS OF DUKES STAGE-D COLORECTAL-CARCINOMA

      Cell proliferation
    69. SILVESTRINI R
      CELL-KINETICS - PROGNOSTIC AND THERAPEUTIC IMPLICATIONS IN HUMAN TUMORS

      Cell proliferation
    70. VENERONI S; ZAFFARONI N; DAIDONE MG; BENINI E; VILLA R; SILVESTRINI R
      EXPRESSION OF P-GLYCOPROTEIN AND IN-VITRO OR IN-VIVO RESISTANCE TO DOXORUBICIN AND CISPLATIN IN BREAST AND OVARIAN CANCERS

      European journal of cancer
    71. VILLA R; ZAFFARONI N; ORLANDI L; BEARZATTO A; COSTA A; SILVESTRINI R
      IN-VITRO EFFECT OF LONIDAMINE ON THE CYTOTOXICITY OF MITOMYCIN-C AND BCNU IN HUMAN COLON ADENOCARCINOMA CELLS

      European journal of cancer
    72. VILLA R; ZAFFARONI N; ORLANDI L; BEARZATTO A; COSTA A; SILVESTRINI R
      IN-VITRO EFFECT OF LONIDAMINE ON THE CYTOTOXICITY OF MITOMYCIN-C AND BCNU IN HUMAN COLON ADENOCARCINOMA CELLS

      European journal of cancer
    73. ZAFFARONI N; ORLANDI L; VILLA R; BEARZATTO A; ROFSTAD EK; SILVESTRINI R
      DNA DOUBLE-STRAND BREAK REPAIR AND RADIATION RESPONSE IN HUMAN TUMOR PRIMARY CULTURES

      International journal of radiation biology
    74. SANFILIPPO O; CAMICI M; TOZZI MG; TURRIANI M; FARANDA A; IPATA PL; SILVESTRINI R
      RELATIONSHIP BETWEEN THE LEVELS OF PURINE SALVAGE PATHWAY ENZYMES ANDCLINICAL BIOLOGICAL AGGRESSIVENESS OF HUMAN COLON-CARCINOMA/

      Cancer biochemistry biophysics
    75. ORLANDI L; ZAFFARONI N; GORNATI D; VENERONI S; SILVESTRINI R
      POTENTIATION OF CISPLATIN CYTOTOXICITY BY LONIDAMINE IN PRIMARY CULTURES OF HUMAN OVARIAN-CANCER

      Anticancer research
    76. SILVESTRINI R; LUISI A; DAIDONE MG; COSTA A; VALENTINIS B; ZUPI G; DAGNANO I; GEIDO E; GIARETTI W; PEPE S; RUGGIERO A; RUSSO A; BAZAN V; FACCHINI A; LALLI E; MAZZINI G; UNGARI S; RIBA S
      QUALITY-CONTROL FOR EVALUATION OF THE S-PHASE FRACTION BY FLOW-CYTOMETRY - A MULTICENTRIC STUDY

      Cytometry
    77. SILVESTRINI R; COSTA A; FARANDA A
      CELL-KINETICS OF COLORECTAL LIVER METASTASES

      Diseases of the colon & rectum
    78. VILLA R; ZAFFARONI N; GORNATI D; COSTA A; SILVESTRINI R
      LACK OF A CORRELATION BETWEEN MICRONUCLEUS FORMATION AND RADIOSENSITIVITY IN ESTABLISHED AND PRIMARY CULTURES OF HUMAN TUMORS

      British Journal of Cancer
    79. SILVESTRINI R; VENERONI S; DAIDONE MG; BENINI E; BORACCHI P; MEZZETTI M; DIFRONZO G; RILKE F; VERONESI U
      THE BCL-2 PROTEIN - A PROGNOSTIC INDICATOR STRONGLY RELATED TO P53 PROTEIN IN LYMPH NODE-NEGATIVE BREAST-CANCER PATIENTS

      Journal of the National Cancer Institute
    80. SILVESTRINI R; ZAFFARONI N; ORLANDI L; ORIANA S
      IN-VITRO CYTOTOXIC ACTIVITY OF TAXOL(R) AND TAXOTERE ON PRIMARY CULTURES AND ESTABLISHED CELL-LINES OF HUMAN OVARIAN-CANCER

      Stem cells
    81. BENINI E; COSTA A; PIZZOCARO G; CAMPO B; MILANI A; TORELLI T; VENERONI S; ORDESI G; PILOTTI S; SILVESTRINI R
      BIOLOGICAL MARKERS IN TRANSURETHRAL BIOPSIES FROM BLADDER-CANCER - PRELIMINARY-RESULTS

      International journal of oncology
    82. SILVESTRINI R
      PROLIFERATION MARKERS IN BREAST-CANCER

      European journal of cancer
    83. SILVESTRINI R; DAIDONE MG; MASTORE M; DIFRONZO G; CORADINI D; BORACCHI P; SQUICCIARINI P; SALVADORI B; VERONESI U
      CELL-KINETICS AS A PREDICTIVE FACTOR IN NODE-POSITIVE BREAST-CANCER TREATED WITH ADJUVANT HORMONE-THERAPY

      Journal of clinical oncology
    84. VALENTINIS B; ZAFFARONI N; STURANI E; MARTEGANI E; SILVESTRINI R
      DETECTION OF DNA POLYMERASE-BETA GENE-EXPRESSION BY COMPETITIVE POLYMERASE CHAIN-REACTION IN HUMAN OVARIAN-CARCINOMA CELLS

      Anticancer research
    85. CAPPELLETTI V; RUEDL C; MIODINI P; FIORAVANTI L; CORADINI D; DIFRONZO G; SILVESTRINI R
      PARACRINE INTERACTION IN COCULTURE OF HORMONE-DEPENDENT AND INDEPENDENT BREAST-CANCER CELLS

      Breast cancer research and treatment
    86. VENERONI S; DAIDONE MG; DIFRONZO G; CAPPELLETTI V; AMADORI D; RICCOBON A; PARADISO A; CORREALE M; SILVESTRINI R
      QUANTITATIVE IMMUNOHISTOCHEMICAL DETERMINATION OF CATHEPSIN-D AND ITSRELATION WITH OTHER VARIABLES

      Breast cancer research and treatment
    87. ZAFFARONI N; VILLA R; ORLANDI L; DEPASCALE A; DELMASTRO S; SILVESTRINI R
      DIFFERENTIAL EFFECT OF 9-BETA-CHLORO-16,16-DIMETHYL PROSTAGLANDIN-E2 (NOCLOPROST) ON THE RADIATION RESPONSE OF HUMAN NORMAL FIBROBLASTS ANDCOLON ADENOCARCINOMA CELLS

      Radiation research
    88. SILVESTRINI R; COSTA A; DERRICO A; FARANDA A; REGALIA E; GRIGIONI W; GENNARI L
      BIOLOGICAL MARKERS IN HEPATOCELLULAR-CARCINOMA - POTENTIAL CLINICAL IMPLICATIONS

      Journal of surgical oncology
    89. SILVESTRINI R; ZAFFARONI N; COSTA A; ORLANDI L; VILLA R; HENDRIKS HR
      FLUNARIZINE AS A MODULATOR OF DOXORUBICIN RESISTANCE IN HUMAN COLON-ADENOCARCINOMA CELLS

      International journal of cancer
    90. SILVESTRINI R; COSTA A; BORACCHI P; GIARDINI R; RILKE F
      CELL-PROLIFERATION AS A LONG-TERM PROGNOSTIC FACTOR IN DIFFUSE LARGE-CELL LYMPHOMAS

      International journal of cancer
    91. SILVESTRINI R; DAGNANO I; FARANDA A; COSTA A; ZUPI G; COSIMELLI M; QUAGLIUOLO V; GIANNARELLI D; GENNARI L; CAVALIERE R
      FLOW CYTOMETRIC ANALYSIS OF PLOIDY IN COLORECTAL-CANCER - A MULTICENTRIC EXPERIENCE

      British Journal of Cancer
    92. SILVESTRINI R; BENINI E; DAIDONE MG; VENERONI S; BORACCHI P; CAPPELLETTI V; DIFRONZO G; VERONESI U
      P53 AS AN INDEPENDENT PROGNOSTIC MARKER IN LYMPH NODE-NEGATIVE BREAST-CANCER PATIENTS

      Journal of the National Cancer Institute


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 00:21:20